Author

David Oupický

Fred and Pamela Buffett Cancer CenterORCID 0000-0003-4710-861XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

Chinmay M. JogdeoiD· 2 shared Ling DingiD· 2 shared Neha KumariiD· 2 shared Aditya SundariD· 1 shared Adrian R. BlackiD· 1 shared Arjun DhiriD· 1 shared Arnob MitroiD· 1 shared Ashish Das· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Chinmay M. JogdeoORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyMolecular Cancer TherapeuticsPeer-reviewedMar 26, 2026

PAMD-Ch17, a Polymeric Analog of Plerixafor, Induces Mitochondrial Dysfunction in T-ALL Cells Independent of CXCR4

Calvin K. Lam, Arjun Dhir, Arnob Mitro…·R. Katherine Hyde

This paper shows PAMD-Ch17, a modified Plerixafor analog, kills T-ALL cells via mitochondrial dysfunction independent of CXCR4 inhibition.

1 citation

𝕏 PostBluesky

BioengineeringbioRxivPreprintMar 21, 2026

Structure-Activity Mapping of Intraperitoneal mRNA-LNPs: Decoupling Tumor and Liver Biodistribution in Pancreatic Cancer

Farhana S. Islam, Ashish Das, Md. Ashaduzzaman…·David Oupický

This study identifies mRNA-LNP formulation features that enhance tumor delivery and reduce liver accumulation in pancreatic cancer.

1 citation

mousebulk RNA-seq

𝕏 PostBluesky

BioengineeringbioRxivPreprintJun 5, 2025

Inhalable Perfluorocarbon RNA Nanocapsules Bypass Immune Clearance While Targeting Lung Epithelial and Lung Tumor Cells

Kasturi Siddhanta, Atefehsadat Monirvaghefi, Aditya Sundar…·David Oupický

This paper develops inhalable perfluorocarbon RNA nanocapsules that bypass immune clearance and target lung cells, showing efficient delivery and therapeutic effects in a lung metastasis model.

2 citations

mouseexperimental assay

𝕏 PostBluesky